10x Genomics: Is the Dip a Buying Opportunity?

10x Genomics stock dips after Piper Sandler issues a Neutral rating! Is this a buying opportunity or a warning sign? Find out why analysts are concerned about price pressures and the slow growth of its spatial market, despite the company's strong technology. We break down the stock's volatile year and what it means for long-term investors. Hosted on Acast. See acast.com/privacy for more information.